Epidemiologic Assessment and Quality of Life Impact of Sinonasal Disease in Cleft Lip and Palate
- PMID: 40751513
- DOI: 10.1002/lary.70002
Epidemiologic Assessment and Quality of Life Impact of Sinonasal Disease in Cleft Lip and Palate
Abstract
Objective: To characterize the prevalence, clinical manifestations, and risk factors of sinonasal pathology in patients with cleft lip and/or palate (CL/P).
Methods: This prospective cohort study included patients aged ≥ 12 years with a history of CL/P, seen at a tertiary craniofacial center from May 2024 to February 2025. Participants completed the Sino-Nasal Outcome Test-22 (SNOT-22) and the Nasal Obstruction Symptom Evaluation (NOSE), assessing sinonasal symptoms. Clinical and demographic data were collected via chart review. Primary outcomes were normalized SNOT-22 and NOSE scores. Statistical analyses included paired and independent t-tests, Pearson correlation, and linear regression to evaluate associations with scores, Veau classification, and age.
Results: Ninety patients were included. Most (83.3%) had non-syndromic CL/P. Chronic rhinosinusitis and allergic rhinitis were reported by 12.2% and 21.1% of participants, respectively. Despite these rates, current sinonasal medication use was high (36.7%). Otolaryngology referrals for sinonasal symptoms were documented in only 21.1% of cases. NOSE scores were significantly higher than SNOT-22 scores (t = -3.65, p < 0.001). After excluding nasal obstruction items in SNOT-22, and quality of life items from both surveys, NOSE scores remained significantly higher (t = -4.65, p < 0.001). No significant differences in total SNOT-22 scores were found across Veau classifications (p = 0.406) or with age (Pearson's r = 0.123, p = 0.250).
Conclusions: Patients with CL/P experience clinically meaningful sinonasal symptoms, predominantly nasal obstruction. Medication use exceeded sinonasal diagnoses, suggesting a higher prevalence of subclinical disease. Incorporating patient-reported outcome measures is essential to uncover the burden of sinonasal pathology and guide multidisciplinary management.
Level of evidence: II.
Keywords: NOSE scale; SNOT‐22; cleft lip and palate (CL/P); sinonasal disease; sinusitis.
© 2025 The American Laryngological, Rhinological and Otological Society, Inc.
References
-
- P. A. Mossey, J. Little, R. G. Munger, M. J. Dixon, and W. C. Shaw, “Cleft Lip and Palate,” Lancet 374, no. 9703 (2009): 1773–1785, https://doi.org/10.1016/S0140‐6736(09)60695‐4.
-
- T. Vyas, P. Gupta, S. Kumar, R. Gupta, T. Gupta, and H. Singh, “Cleft of Lip and Palate: A Review,” Journal of Family Medicine and Primary Care 9, no. 6 (2020): 2621–2625, https://doi.org/10.4103/jfmpc.jfmpc_472_20.
-
- R. S. Zhang, L. O. Lin, I. C. Hoppe, et al., “Nasal Obstruction in Children With Cleft Lip and Palate: Results of a Cross‐Sectional Study Utilizing the NOSE Scale,” Cleft Palate Craniofacial Journal 56, no. 2 (2019): 177–186, https://doi.org/10.1177/1055665618772400.
-
- H. Chiang, R. Shah, C. Washabaugh, and D. O. Frank‐Ito, “Nasal Airway Obstruction in Patients With Cleft Lip Nasal Deformity: A Systematic Review,” Journal of Plastic, Reconstructive & Aesthetic Surgery 92 (2024): 48–60, https://doi.org/10.1016/j.bjps.2024.02.061.
-
- A. R. Sedaghat, E. C. Kuan, and G. K. Scadding, “Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors,” Journal of Allergy and Clinical Immunology: In Practice 10, no. 6 (2022): 1395–1403, https://doi.org/10.1016/j.jaip.2022.01.016.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous